Kevin O’Leary: Psychedelic drugs ‘far exceed’ cannabis investment potential – CNBC
Kevin O’Leary: Psychedelic drugs ‘far exceed’ cannabis investment potential CNBC >View original article Contributor:
Kevin O’Leary: Psychedelic drugs ‘far exceed’ cannabis investment potential CNBC >View original article Contributor:
“I don’t see a lot going well for them at this point,” said one analyst….
Low-carb, healthy alternatives to pasta Medical News Today >View original article Contributor:
A new study questions that figure, known as Dunbar’s number. The Oxford professor for whom…
The F.D.A.’s authorization of Pfizer’s Covid shot for 12- to 15-year-olds is a milestone in…
New tests for respiratory illnesses can look for more than 20 pathogens at a time….
The hope is that new treatments will encourage people to think of obesity as a…
Recent conservative legislation has targeted a class of drugs used to treat transgender adolescents. But…
In recent weeks and months, as people have ventured out more often, business has jumped…
How a crisis can help us rethink space and reimagine the future. View original article…